{Reference Type}: Case Reports
{Title}: Successful treatment and remission of advanced testicular cancer after COVID-19 infection during induction chemotherapy.
{Author}: Kitano G;Tanaka S;Kato M;Itoh N;Kojima T;
{Journal}: IJU Case Rep
{Volume}: 7
{Issue}: 4
{Year}: 2024 Jul
暂无{DOI}: 10.1002/iju5.12726
{Abstract}: <B>UNASSIGNED: </B>We report a case of advanced testicular cancer cured by early and appropriate resumption of chemotherapy even after COVID-19 infection during induction chemotherapy.<BR><B>UNASSIGNED: </B>The patient was a healthy 36-year-old male. The diagnosis was a stage IIIB nonseminoma (pT2N2M1a). On day 14 of the first chemotherapy cycle, the patient was diagnosed with mild COVID-19. The second chemotherapy cycle was initiated with a 1-day delay (on day 10 after the COVID-19 diagnosis). The patient achieved remission with minimal postponement of chemotherapy.<BR><B>UNASSIGNED: </B>Only a few case reports have described the resumption of anticancer chemotherapy in patients with COVID-19. In deciding when to resume chemotherapy after COVID-19 infection, it is essential to consider factors such as cancer type, progression, and severity of COVID-19 and should be tailored to individual patient needs.